TEVA PHARMACEUTICAL-SP ADR (TEVA) Stock Income Statement
NYSE:TEVA • US8816242098
Current stock price
28.73 USD
-0.71 (-2.41%)
At close:
28.77 USD
+0.04 (+0.14%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 17.26B | 16.54B | 15.85B | 14.93B | 15.88B | |||
| Minority Interest Expense | -7.00M | 320.00M | 56.00M | 53.00M | -39.00M | |||
| Cost Of Goods | 8.13B | 8.25B | 7.87B | 7.49B | 8.01B | |||
| Gross Profit | 9.12B | 8.29B | 7.98B | 7.44B | 7.86B | |||
| Operating Expenses | 4.99B | 4.70B | 4.44B | 4.25B | 4.45B | |||
| Research and Development | 1.01B | 998.00M | 953.00M | 838.00M | 967.00M | |||
| Selling, General, and Administrative Expenses | 3.97B | 3.70B | 3.50B | 3.44B | 3.40B | |||
| Operating Income | 4.14B | 3.59B | 3.54B | 3.19B | 3.42B | |||
| Interest Income/Expense | -865.00M | -933.00M | -991.00M | -904.00M | -988.00M | |||
| Other Income/Expense | -69.00M | -48.00M | -66.00M | -62.00M | -70.00M | |||
| Non Recurring Items | -1.98B | -3.89B | -3.11B | -5.38B | -1.70B | |||
| Income Before Taxes | 1.22B | -1.28B | -624.00M | -3.16B | 658.00M | |||
| Income Tax | -180.00M | 676.00M | -7.00M | -643.00M | 211.00M | |||
| Net Income | 1.41B | -1.64B | -559.00M | -2.45B | 417.00M | |||
| EBITDA | 5.14B | 4.65B | 4.69B | 4.49B | 4.75B | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 1.24 | -1.48 | -0.51 | -2.25 | 0.38 | |||
| Non GAAP EPS | 2.98 | 2.54 | 2.61 | 2.58 | 2.63 | |||
| Statistics | ||||||||
| Gross Profit Margin | 52.87% | 50.12% | 50.33% | 49.84% | 49.53% | |||
| Profit Margin | 8.17% | -9.91% | -3.53% | -16.39% | 2.63% | |||
| Operating Profit Margin | 23.98% | 21.69% | 22.34% | 21.34% | 21.53% | |||
All data in USD